Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study by Clifton O. Bingham, Shawn Black, Natalie J. Shiff, Stephen Xu, Wayne Langholff, Jeffrey R. Curtis

Get full text

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study by Aaron Broadwell, Joy Schechtman, Douglas Conaway, Alan Kivitz, Natalie J. Shiff, Shawn Black, Stephen Xu, Wayne Langholff, Sergio Schwartzman, Jeffrey R. Curtis

Get full text

Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis by Claire E. H. Barber, Cheryl Barnabe, Susanne Benseler, Ricky Chin, Nicole Johnson, Nadia Luca, Paivi Miettunen, Marinka Twilt, Dwaraka Veeramreddy, Natalie J. Shiff, Heinrike Schmeling

Get full text

Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study by Atul Deodhar, Natalie J. Shiff, Cinty Gong, Eric K. H. Chan, Elizabeth C. Hsia, Kim Hung Lo, Alianu Akawung, Lilianne Kim, Stephen Xu, John D. Reveille

Get full text

Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study by Laure Gossec, Peter Nash, Philip J Mease, Emmanouil Rampakakis, Laura C Coates, Philip S Helliwell, Alexa P Kollmeier, Xie L Xu, May Shawi, Miriam Zimmermann, Natalie J Shiff

Get full text

Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort by Tara McGrath, Jaime Guzman, Lori Tucker, Natalie J. Shiff, Maryna Yaskina, Susan Tupper, Dax G. Rumsey, for the Research in Arthritis in Canadian Children Emphasizing Outcomes (ReACCh-Out) Investigators

Get full text

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Regi... by Philip J. Mease, Alexis Ogdie, John Tesser, Natalie J. Shiff, Iris Lin, Soumya D. Chakravarty, Michael Kelleman, Rhiannon Dodge, Robert R. McLean, Aaron Broadwell, Arthur Kavanaugh, Joseph F. Merola

Get full text

Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis by Jeffrey R. Curtis, Iain B. McInnes, Proton Rahman, Dafna D. Gladman, Steven Peterson, Feifei Yang, Oluwakayode Adejoro, Alexa P. Kollmeier, Natalie J. Shiff, Chenglong Han, May Shawi, William Tillett, Philip J. Mease

Get full text

Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care by Claire E.H. Barber, Lisa M. Lix, Diane Lacaille, Deborah A. Marshall, Kristine Kroeker, Susanne Benseler, Marinka Twilt, Heinrike Schmeling, Cheryl Barnabe, Glen S. Hazlewood, Vivian Bykerk, Joanne Homik, J. Carter Thorne, Jennifer Burt, Dianne Mosher, Steven Katz, Natalie J. Shiff

Get full text